Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
NCT01766297
This study is recruiting at 9 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy. This study is being done to see if proton radiation therapy will prove to be beneficial for women with early stage breast cancer. A clinical study is necessary to compare the results (good or bad) of proton radiation therapy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Breast Cancer
- Breast Neoplasm
- Breast Tumor
- Cancer of the Breast
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 50 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Proton Collaborative Group
- Last updated on ClinicalTrials.gov
- September 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Mayo Clinic · Scottsdale, AZ
California · 1
- California Protons Cancer Therapy Center · San Diego, CA
Illinois · 1
- Northwestern Medicine Chicago Proton Center · Warrenville, IL
Maryland · 1
- Maryland Proton Treatment Center · Baltimore, MD
Michigan · 1
- McLaren Proton Therapy Center · Flint, MI
New York · 1
- New York Proton Center · New York, NY
Oklahoma · 1
- Oklahoma Proton Center · Oklahoma City, OK
Virginia · 2
- Inova Schar Cancer Institute · Fairfax, VA
- Hampton University Proton Therapy Institute · Hampton, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.